Skip to main content
Clinical Trials/NCT01108497
NCT01108497TerminatedNot Applicable

Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia

Stanford University1 site in 1 country235 target enrollmentStarted: July 2001Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
235
Locations
1
Primary Endpoint
Gene Expression

Study Overview

Brief Summary

We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All children who present at Packard hospital with a new diagnosis or relapse of acute leukemia will be eligible. There is no bias in regards to age range, gender or ethnic background.
  • Signed informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Gene Expression

Time Frame: days 0, 8, 22 or 29

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials